Due in large part to the effective deployment of prescription drug monitoring programs (PDMPs), opioid prescribing is at a 10-year low. Unfortunately, with overdose deaths at an all-time high, it is clear that tracking the dispensing of controlled substances is necessary but not sufficient to support prescribing decisions that lead to a reduction in substance use disorders. To meet this need, Appriss Health, the leading PDMP provider, and hc1.com, the leader in precision health, have partnered to deliver hc1 Opioid Advisor™.
During the hc1 Opioid Advisor™ demo, you’ll see how toxicology labs are able to:
hc1 Opioid Advisor™, delivered via a strategic partnership with Appriss Health, was thoughtfully designed to comply with state PDMP regulations and to satisfy state mandated use laws. The solution automatically compares toxicology results with PDMP data, providing clinical decision support to personalize prescribing of controlled substances, including opioids.